Table 2 Significant (P < 5e−08) SNPs and genetic loci associated with bacterial and viral infections in the GWAS.

From: A genome-wide association study in a large community-based cohort identifies multiple loci associated with susceptibility to bacterial and viral infections

Phenotype

SNP

CH

Position (b37)

Effect allele

Other allele

EAF cases

EAF controls

Odds ratio (95% CI)

Beta

SE

P

MACH-Rsq

Nearby genes (+ / − 100 kb)

Abdominal infections

rs6717024

2

144,308,780

C

G

0.2

0.18

1.133 (1.111–1.156)

0.125

0.010

1.22e−34

1.00

ARHGAP15

rs4333882

1

234,352,899

G

A

0.2

0.19

1.081 (1.060–1.103)

0.078

0.010

2.14e−14

0.97

MIR4671, SLC35F3

rs7609897

3

15,502,681

T

G

0.2

0.21

0.925 (0.907–0.943)

− 0.078

0.010

9.76e−14

0.91

COLQ, EAF1, HACL1, METTL6, MIR4270

rs760364725

19

38,757,315

CA

C

0.49

0.48

1.062 (1.045–1.079)

0.060

0.008

5.59e−13

0.94

C19orf33, CATSPERG, DPF1, KCNK6, PPP1R14A, SIPA1L3, SPINT2, YIF1B

rs61823192

1

219,294,570

T

C

0.026

0.03

0.828 (0.785–0.873)

− 0.189

0.027

1.26e−12

0.90

LYPLAL1, LYPLAL1-DT

rs1802575

2

56,093,204

C

G

0.14

0.13

1.081 (1.056–1.107)

0.078

0.012

1.56e−11

1.00

EFEMP1, MIR217HG

rs11428277

10

101,425,013

G

GA

0.19

0.18

1.075 (1.052–1.098)

0.072

0.011

1.69e−11

0.91

COX15, CUTC, ENTPD7, SLC25A28

rs570640158

6

32,517,793

C

T

0.27

0.26

1.070 (1.050–1.092)

0.068

0.010

2.13e−11

0.81

HLA-DQA1, HLA-DRB1, HLA-DRB5, HLA-DRB6

rs4782673

16

84,884,072

T

G

0.28

0.3

0.945 (0.928–0.961)

− 0.057

0.009

1.37e−10

1.00

CRISPLD2, USP10

rs7464710

8

120,624,386

G

C

0.25

0.26

0.943 (0.926–0.959)

− 0.059

0.009

4.13e−10

0.98

ENPP2

rs2049865

8

116,588,546

C

A

0.41

0.42

0.950 (0.935–0.965)

− 0.051

0.008

4.67e−10

0.98

TRPS1

rs61817723

1

151,920,865

A

G

0.27

0.28

0.945 (0.928–0.961)

− 0.057

0.009

4.71e−10

0.99

C2CD4D-AS1, NBPF18P, S100A10, S100A11, THEM4, THEM5

rs2276068

11

70,007,484

C

G

0.49

0.48

1.050 (1.034–1.067)

0.049

0.008

1.04e−09

1.00

ANO1, FADD, LINC02584, LOC101928443

rs9372625

6

98,344,031

A

G

0.37

0.38

0.951 (0.936–0.966)

− 0.050

0.008

2.02e−09

0.99

 

rs2280028

16

86,233,413

A

G

0.13

0.14

0.932 (0.911–0.955)

− 0.070

0.012

3.23e−09

0.99

LINC01081, LINC01082, LINC02135

rs71472433

15

40,649,609

C

A

0.17

0.17

1.064 (1.041–1.087)

0.062

0.011

5.24e−09

0.99

ANKRD63, BAHD1, BUB1B-PAK6, CCDC9B, DISP2, INAFM2, IVD, KNSTRN, PAK6, PHGR1, PLCB2

rs2973068

5

37,778,273

G

C

0.24

0.25

0.947 (0.931–0.964)

− 0.054

0.009

8.15e−09

0.99

GDNF, GDNF-AS1, WDR70

rs761264338

7

102,444,156

GGAAG

G

0.34

0.33

1.050 (1.032–1.069)

0.049

0.009

1.03e−08

0.98

FAM185A, FBXL13, RASA4DP

rs1888693

10

18,440,444

A

G

0.33

0.34

0.952 (0.936–0.969)

− 0.049

0.009

1.14e−08

1.00

CACNB2

rs3732760

3

151,074,941

C

A

0.38

0.37

1.048 (1.032–1.065)

0.047

0.008

1.17e−08

1.00

GPR87, IGSF10, MED12L, P2RY12, P2RY13, P2RY14

rs575909118

11

15,065,235

CT

C

0.27

0.27

1.053 (1.035–1.072)

0.052

0.009

1.40e−08

0.98

CALCA, CALCB, INSC

rs11030119

11

27,728,102

A

G

0.3

0.31

0.951 (0.935–0.968)

− 0.050

0.009

1.44e−08

1.00

BDNF, BDNF-AS, LINC00678

rs60731259

7

73,439,465

CA

C

0.066

0.061

1.096 (1.063–1.131)

0.092

0.016

1.96e−08

0.99

ELN, LIMK1

rs9411377

9

136,145,404

A

C

0.28

0.29

0.950 (0.934–0.967)

− 0.051

0.009

2.01e−08

0.96

MED22, OBP2B, RPL7A, SNORD24, SNORD36A, SNORD36B, SNORD36C, STKLD1, SURF1, SURF2, SURF4, SURF6

rs377411728

18

6,305,754

T

C

0.00071

0.00031

2.641 (1.878–3.714)

0.971

0.174

2.42e−08

0.83

L3MBTL4, L3MBTL4-AS1, MIR4317

Not available

1

214,458,533

C

CT

0.46

0.45

1.046 (1.030–1.063)

0.045

0.008

3.67e−08

0.99

PTPN14, SMYD2

Gastroenteritis

rs115809651

4

162,414,623

A

G

0.0014

0.00046

3.525 (2.359–5.269)

1.260

0.205

8.07e−10

0.86

FSTL5

rs138491114

22

47,432,980

A

G

0.0035

0.0018

1.986 (1.557–2.532)

0.686

0.124

3.14e−08

0.97

TBC1D22A

rs772878892

16

49,404,415

G

A

0.0011

0.00032

3.597 (2.274–5.690)

1.280

0.234

4.77e−08

0.90

C16orf78, CBLN1

 a. Bacterial gastroenteritis

rs143977447

5

164,646,152

A

C

0.011

0.0053

2.375 (1.787–3.156)

0.865

0.145

2.20e−09

0.85

 

rs547484470

7

68,931,296

A

C

0.0045

0.0014

3.710 (2.396–5.744)

1.311

0.223

4.13e−09

0.88

 

 b. Viral gastroenteritis

rs116879283

7

52,434,143

C

T

0.017

0.0063

2.956 (2.033–4.299)

1.084

0.191

1.49e−08

0.90

 

Heart infections

rs564399474

13

54,865,197

G

A

0.016

0.0039

4.527 (2.930–6.994)

1.510

0.222

1.02e−11

0.93

MIR1297

rs182592259

14

96,788,318

A

T

0.016

0.005

3.589 (2.323–5.546)

1.278

0.222

8.73e−09

0.88

AK7, ATG2B, BDKRB1, BDKRB2, GSKIP

rs139809494

17

79,796,214

T

C

0.019

0.0064

3.139 (2.117–4.655)

1.144

0.201

1.30e−08

0.96

ALYREF, ANAPC11, ARHGDIA, GCGR, MAFG, MAFG-DT, MCRIP1, NPB, P4HB, PCYT2, PPP1R27, PYCR1, SIRT7

rs2181386

14

94,039,907

G

A

0.16

0.12

1.490 (1.294–1.716)

0.399

0.072

3.51e−08

1.00

UNC79

Respiratory tract infections

rs28752520

6

32,584,739

C

T

0.24

0.25

0.931 (0.911–0.951)

− 0.072

0.011

1.77e−10

0.99

HLA-DQA1, HLA-DQB1, HLA-DQB1-AS1, HLA-DRB1, HLA-DRB5, HLA-DRB6

Not available

9

128,648,077

ATG

A

0.34

0.35

0.937 (0.919–0.956)

− 0.065

0.010

1.94e−10

0.98

PBX3

 a. Bacterial pneumonia

rs374402947

16

89,154,513

T

C

0.0014

0.00048

3.391 (2.300–4.998)

1.221

0.198

6.86e−10

0.88

ACSF3, CDH15, LINC00304, LINC02138

rs77438700

15

78,906,637

G

A

0.064

0.074

0.839 (0.795–0.887)

− 0.175

0.028

7.72e−10

0.97

CHRNA3, CHRNA5, CHRNB4, HYKK, PSMA4

rs532298826

4

138,378,079

A

T

0.0016

0.00064

3.056 (2.093–4.461)

1.117

0.193

6.62e−09

0.80

LINC02172, PCDH18

rs763947133

5

127,719,333

T

C

0.00098

0.00029

3.971 (2.466–6.393)

1.379

0.243

1.33e−08

0.81

FBN2

 b. Influenza and viral pneumonia

rs376768393

3

154,969,551

C

T

0.021

0.0064

3.850 (2.434–6.090)

1.348

0.234

8.57e−09

0.87

DWORF, LINC01487, MME

Sepsis

rs532825748

1

169,752,583

G

A

0.0078

0.0041

2.018 (1.586–2.568)

0.702

0.123

1.13e−08

0.89

C1orf112, METTL18, SCYL3, SELE, SELL

rs147389769

2

231,527,107

T

C

0.007

0.0036

2.130 (1.638–2.769)

0.756

0.134

1.60e−08

0.83

CAB39, LINC01907

rs564716204

4

151,664,401

T

C

0.0027

0.00092

3.353 (2.200–5.111)

1.210

0.215

1.90e−08

0.82

LRBA

rs539059490

6

122,025,326

G

T

0.0073

0.0039

2.006 (1.567–2.568)

0.696

0.126

3.65e−08

0.89

 

Sexually transmitted diseases

rs62441491

7

41,892,859

A

G

0.056

0.018

3.438 (2.274–5.199)

1.235

0.211

4.73e−09

0.94

INHBA-AS1

Skin infections

rs6595799

5

127,408,683

C

T

0.28

0.27

1.092 (1.058–1.127)

0.088

0.016

2.39e−08

0.98

LINC01184, SLC12A2

Specified viral infections

rs568156598

7

94,453,230

G

A

0.0029

0.00091

3.747 (2.397–5.858)

1.321

0.228

6.68e−09

0.85

PPP1R9A

Urinary tract infections (UTI)

rs771331833

8

118,513,358

A

C

0.0013

0.00049

2.989 (2.096–4.262)

1.095

0.181

1.62e−09

0.93

MED30

Not available

3

47,875,364

A

AT

0.009

0.0064

1.471 (1.285–1.684)

0.386

0.069

2.81e−08

0.90

DHX30, MAP4, MIR1226, SMARCC1

rs189319388

3

7,867,797

T

C

0.0077

0.0055

1.527 (1.313–1.775)

0.423

0.077

4.63e−08

0.81

GRM7

 a. Cystitis

rs192629083

7

14,037,179

T

C

0.0077

0.0025

3.702 (2.396–5.721)

1.309

0.222

3.50e−09

0.86

ETV1

rs77261774

4

60,641,124

A

G

0.034

0.02

1.788 (1.461–2.188)

0.581

0.103

1.49e−08

1.00

LINC02429

Urogenital (non-UTI) infections

rs188692128

8

126,584,263

T

C

0.005

0.0017

3.589 (2.282–5.645)

1.278

0.231

3.13e−08

0.85

 

Not available

1

240,891,604

T

TA

0.0052

0.0018

3.456 (2.219–5.381)

1.240

0.226

4.30e−08

0.83

RGS7

  1. Phenotypes are listed in alphabetical order.